Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes

NCT03362112 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.

NCT NCT03362112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03362112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Observational
Overall status
Completed
Start date
January 30, 2015
Completion date
June 1, 2017
Enrollment
1,713 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes